Atezolizumab in Combination with Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery for Patients with Newly-Diagnosed Advanced-Stage Epithelial Ovarian Cancer(Bio-Marker Lab Clinical Research)

Administered By

Awarded By

Contributors

Start/End

  • February 2, 2018 - February 1, 2022